000518 四环生物
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-3.081-14.490-8.389-5.5804.350
总资产报酬率 ROA (%)-2.231-10.760-6.347-4.2873.138
投入资产回报率 ROIC (%)-2.723-12.951-7.593-5.1804.483

边际利润分析
销售毛利率 (%)68.85469.76171.03569.41857.868
营业利润率 (%)-10.004-32.517-20.047-10.1037.884
息税前利润/营业总收入 (%)-8.940-32.725-19.249-9.5367.400
净利润/营业总收入 (%)-9.957-34.158-19.723-10.9055.472

收益指标分析
经营活动净收益/利润总额(%)101.19665.80676.61179.81283.518
价值变动净收益/利润总额(%)-0.094-2.1750.4871.507-0.069
营业外收支净额/利润总额(%)-0.4693.618-1.0281.602-9.356

偿债能力分析
流动比率 (X)4.1684.3114.8605.1314.859
速动比率 (X)0.8250.8541.3431.5691.597
资产负债率 (%)23.45422.42119.58919.08316.834
带息债务/全部投入资本 (%)6.0376.0375.2024.463--
股东权益/带息债务 (%)1,462.8711,464.9781,734.0842,034.4231,883.013
股东权益/负债合计 (%)306.578325.050385.412397.306462.156
利息保障倍数 (X)-8.789-32.322-32.414-13.01938.810

营运能力分析
应收账款周转天数 (天)114.818129.931146.201130.0110.000
存货周转天数 (天)2,273.0612,066.5601,930.9871,475.4800.000